Costly Drug Is Denied, Medicaid Takes Heat

Vertex Pharmaceuticals' $300,000-a-year cystic-fibrosis drug has sparked a battle in Arkansas, illustrating the dilemma faced by cash-strapped government insurance programs.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news